Historique
Nouveauté
![Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs [Commentary]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_79380.webp?v=1771268297)
J. GREBELY ;
J. BRUNEAU ;
J. V. LAZARUS ;
O. DALGARD ;
P. BRUGGMANN ;
C. TRELOAR ;
M. HICKMAN ;
M. HELLARD ;
T. ROBERTS ;
L. CROOKS ;
H. MIDGARD ;
S. LARNEY ;
L. DEGENHARDT ;
H. ALHO ;
J. BYRNE ;
J. F. DILLON ;
J. J. FELD ;
G. FOSTER ;
D. GOLDBERG ;
A. R. LLOYD ;
J. REIMER ;
G. ROBAEYS ;
M. TORRENS ;
N. WRIGHT ;
I. MAREMMANI ;
B. L. NORTON ;
A. H. LITWIN ;
G. J. DORE ;
International Network on Hepatitis in Substance Users
|
2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique
Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]
